EU Accepts Aspen Offer To Slash Prices On Cancer Drugs
The European Union's antitrust enforcers accepted Aspen Pharmacare Holdings Ltd.'s offer to lower prices of six cancer medications by an average of 73% on Wednesday, saying the concessions would provide "fast,...To view the full article, register now.
Already a subscriber? Click here to view full article